Extreme Lipids Repository

Active, not recruitingOBSERVATIONAL
Enrollment

250

Participants

Timeline

Start Date

May 10, 2019

Primary Completion Date

May 31, 2029

Study Completion Date

May 31, 2029

Conditions
Lipoprotein Disorder
Interventions
OTHER

No intervention is involved in this study

No intervention is involved in this study

Trial Locations (2)

75390

Parkland Health Hospital System, Dallas

University of Texas Southwestern Medical Center - Ambulatory Clinic, Dallas

All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

University of Texas Southwestern Medical Center

OTHER

NCT04156997 - Extreme Lipids Repository | Biotech Hunter | Biotech Hunter